# A Placebo-Controlled, Two-Part Study, Oral Dose to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CNTX-6970 in Healthy Subjects

> **NCT03787004** · PHASE1 · COMPLETED · sponsor: **Centrexion Therapeutics** · enrollment: 62 (actual)

## Conditions studied

- Chronic Pain
- Nociceptive Pain

## Interventions

- **DRUG:** CNTX-6970
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03787004
- **Lead sponsor:** Centrexion Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-14
- **Primary completion:** 2018-08-19
- **Final completion:** 2018-09-26
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2018-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03787004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03787004, "A Placebo-Controlled, Two-Part Study, Oral Dose to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CNTX-6970 in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03787004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*